{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:14:01Z","timestamp":1774296841642,"version":"3.50.1"},"reference-count":52,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The inoculation of live, nonattenuated<jats:italic>Leishmania major<\/jats:italic>to produce a lesion in a selected site that heals, referred to as leishmanization, is to date the only vaccine against leishmaniasis that has proven to be effective in humans. Its use has been restricted or abandoned entirely, however, due to safety concerns. In an attempt to develop a leishmanization protocol that minimizes pathology while maintaining long-term protection, live parasites were coinjected with CpG-containing immunostimulatory oligodeoxynucleotides (CpG ODNs) alone or in combination with whole-cell lysates of heat-killed<jats:italic>L. major<\/jats:italic>promastigotes bound to alum (ALM). C57BL\/6 mice infected intradermally by using<jats:italic>L. major<\/jats:italic>plus CpG ODN with or without ALM developed few or no dermal lesions and showed an early containment of parasite growth, while mice infected with<jats:italic>L. major<\/jats:italic>with or without ALM developed sizable dermal lesions that required up to 10 weeks to heal. The CpG ODNs provoked a transient inflammation that included an early recruitment and accumulation of gamma interferon-producing CD4<jats:sup>+<\/jats:sup>lymphocytes in the site. Attenuation of the live vaccine did not compromise its ability to confer long-term immunity, as mice receiving<jats:italic>L. major<\/jats:italic>and CpG ODN plus ALM were totally protected against reinfection with<jats:italic>L. major<\/jats:italic>for up to 6 months. By comparison, the immunity elicited by two efficient nonlive vaccines began to wane by 6 months. Our results suggest that immune modulation using CpG ODNs might be a practical approach to improving the safety of a highly effective live vaccine that has already been widely applied.<\/jats:p>","DOI":"10.1128\/iai.71.9.5121-5129.2003","type":"journal-article","created":{"date-parts":[[2003,8,21]],"date-time":"2003-08-21T21:40:43Z","timestamp":1061502043000},"page":"5121-5129","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":62,"title":["Coinjection with CpG-Containing Immunostimulatory Oligodeoxynucleotides Reduces the Pathogenicity of a Live Vaccine against Cutaneous Leishmaniasis but Maintains Its Potency and Durability"],"prefix":"10.1128","volume":"71","author":[{"given":"Susana","family":"Mendez","sequence":"first","affiliation":[{"name":"Laboratory of Parasitic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Tabbara","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine","family":"Belkaid","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Bertholet","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Verthelyi","sequence":"additional","affiliation":[{"name":"Division of Therapeutic Proteins"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Klinman","sequence":"additional","affiliation":[{"name":"Section of Retroviral Immunology, Cellular Immunology Section, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Seder","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Sacks","sequence":"additional","affiliation":[{"name":"Laboratory of Parasitic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1099\/13500872-141-7-1585"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7904381"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(96)00071-5"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.10.1497"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.10.1941"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.2.969"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01152"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.8.3992"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1636090"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.6.2828-2836.2002"},{"key":"e_1_3_1_12_2","first-page":"401","volume":"1","year":"1987","unstructured":"Convit, J., P. L. Castellanos, A. Rondon, M. E. Pinardi, M. Ulrich, M. Castes, B. Bloom, and L. Garcia. 1987. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet1:401-405.","journal-title":"Lancet"},{"key":"e_1_3_1_13_2","unstructured":"Gafurov I. M. 1999. Experience in controlling and preventing zoonotic cutaneous leishmaniasis in Uzbekistan. Med. Parazitol. (Mosk) 1 : 58-59. (In Russian.)"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00427-3"},{"key":"e_1_3_1_15_2","first-page":"259","volume":"47","year":"1980","unstructured":"Greenblatt, C. L. 1980. The present and future of vaccination for cutaneous leishmaniasis. Prog. Clin. Biol. Res.47:259-285.","journal-title":"Prog. Clin. Biol. Res."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/4000"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1137"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.2.915"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.11.4261-4267.1995"},{"key":"e_1_3_1_20_2","first-page":"39","volume":"43","year":"1992","unstructured":"Hashemi-Fesharki, R., S. Alle-Agha, P. Ahourai, E. Djavadian, A. Taghavi, A. Golabi, M. Kamail, K. Esmail-Nia, H. Ghafari, F. Mofasali, and R. Kheirol-Omour. 1992. Vaccine preparation and quality control of killed Leishmania major. Arch. Inst. Razi43:39-50.","journal-title":"Arch. Inst. Razi"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.132.1.450","volume":"132","year":"1984","unstructured":"Howard, J. G., F. Y. Liew, C. Hale, and S. Nicklin. 1984. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. J. Immunol.132:450-455.","journal-title":"J. Immunol."},{"key":"e_1_3_1_22_2","first-page":"306","volume":"74","year":"1981","unstructured":"Kellina, O. I. 1981. Problem and current lines in investigations on the epidemiology of leishmaniasis and its control in the U.S.S.R. Bull. Soc. Pathol. Exot. Fil.74:306-318.","journal-title":"Bull. Soc. Pathol. Exot. Fil."},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03128-7"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.12.5205-5213.1993"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00832004"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.7.2879"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(99)00048-5"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/expr.1997.4183"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00376-6"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.8.5122"},{"key":"e_1_3_1_31_2","first-page":"83","volume":"89","year":"1995","unstructured":"Modabber, F. 1995. Vaccines against leishmaniasis. Ann. Trop. Med. Parasitol.89(Suppl. 1):83-88.","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00220-5"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7725103"},{"key":"e_1_3_1_34_2","first-page":"377","volume":"76","year":"1983","unstructured":"Nadim, A., E. Javadian, G. Tahvildar-Bidruni, and M. Ghorbani. 1983. Effectiveness of leishmanization in the control of cutaneous leishmaniasis. Bull. Soc. Pathol. Exot. Fil.76:377-383.","journal-title":"Bull. Soc. Pathol. Exot. Fil."},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00738.2001"},{"key":"e_1_3_1_36_2","first-page":"126","volume":"23","year":"1976","unstructured":"Preston, P. M., and D. C. Dumonde. 1976. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin. Exp. Immunol.23:126-138.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00081-0"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020147"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.1993.tb00587.x"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09552-X"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.160.8.3949","volume":"160","year":"1998","unstructured":"Sjolander, A., T. M. Baldwin, J. M. Curtis, and E. Handman. 1998. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. J. Immunol.160:3949-3957.","journal-title":"J. Immunol."},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.8.3719-3726.1999"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200101)31:1<301::AID-IMMU301>3.0.CO;2-K"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.160197797"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.2000.1735"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.22.10267"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.12.6967"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01850.x"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.12.6970"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3279-3289.1998"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90079-5"},{"key":"e_1_3_1_52_2","first-page":"1","volume":"85","year":"1995","unstructured":"Xu, D., S. J. McSorley, S. N. Chatfield, G. Dougan, and F. Y. Liew. 1995. Protection against Leishmania major infection in genetically susceptible BALB\/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA\u2212 AroD\u2212). Immunology85:1-7.","journal-title":"Immunology"},{"key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.160.8.3627","volume":"160","year":"1998","unstructured":"Zimmermann, S., O. Egeter, S. Hausmann, G. B. Lipford, M. Rocken, H. Wagner, and K. Heeg. 1998. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol.160:3627-3630.","journal-title":"J. Immunol."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.9.5121-5129.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.9.5121-5129.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T20:48:27Z","timestamp":1682542107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.71.9.5121-5129.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1128\/IAI.71.9.5121-5129.2003"],"URL":"https:\/\/doi.org\/10.1128\/iai.71.9.5121-5129.2003","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"2003-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-06-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}